Michael Sundström new director of CMM
The board of the Center for Molecular Medicine (CMM) has appointed Michael Sundström as the new director. Michael assumed his position on April 1, 2022.
Michael Sundström received his PhD from Uppsala University, ollowed by postdoctoral studies at Karolinska Institutet. Today, he has more than 30 years of international experience from pharmaceutical and biotechnology organizations, where he has also held several senior positions. Since 2014, he is the Scientific Director for SGC Karolinska Laboratory, which is located at CMM.
As director, Michael Sundström will work in close collaboration with Karolinska University Hospital, Karolinska Institutet and Region Stockholm in order to continue strengthening the connection between clinical and molecular research. Together with the scientists, the CMM Board, CMM Steering Group and support personnel, he will further develop the Center as a leading and attractive cross-disciplinary research environment.